ReviewCardiovascular diabetology. Endocrinology reports2026
Use of continuous glucose monitoring (CGM) in diabetes management in Africa: opportunities, challenges, and future prospects.
Review in Cardiovascular diabetology. Endocrinology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Younger Age is Associated with Treatment and Complication Outcomes Among Type 2 Diabetes Mellitus Patients in Kigali University Teaching Hospital.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus represents a growing public health crisis across Africa, with prevalence rates increasing due to urbanization, lifestyle transitions, and epidemiological transition. Despite numerous technological advances in diabetes management, including continuous glucose monitoring (CGM), access to these innovations remains limited across the continent.
objectiveThis narrative review examines the current state, opportunities, challenges, and prospects of CGM technology in African diabetes care, with emphasis on the socioeconomic, infrastructural, and cultural factors influencing implementation.
methodsA comprehensive review of peer-reviewed literature, clinical trials, and implementation studies from African contexts was conducted, incorporating evidence on CGM technology, diabetes epidemiology, healthcare systems, and policy frameworks across African nations.
resultsCGM technology offers substantial benefits for glycaemic control, complication reduction, and patient empowerment. However, widespread adoption in Africa faces significant barriers including prohibitive costs, limited healthcare infrastructure, supply chain challenges, inadequate healthcare workforce training, and sociocultural factors. Emerging clinical trials in South Africa, Kenya, and Malawi demonstrate feasibility and clinical benefits, though large-scale implementation remains constrained.
conclusionsWhile CGM holds important potential at transforming African diabetes care, successful integration requires multisectoral collaboration, innovative financing mechanisms, capacity building, and feasible implementation strategies. Policy frameworks that support equitable access, regulatory harmonization, and sustainable scale-up models are essential for realizing CGM's full potential across the continent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.